During the recent session, Biomarin Pharmaceutical Inc. (NASDAQ:BMRN)’s traded shares were 4.98 million, with the beta value of the company hitting 0.31. At the last check today, the stock’s price was $83.21, reflecting an intraday loss of -8.76% or -$7.99. The 52-week high for the BMRN share is $99.56, that puts it down -19.65 from that peak though still a striking 8.64% gain since the share price plummeted to a 52-week low of $76.02. The company’s market capitalization is $15.79B, and the average trade volume was 1.41 million shares over the past three months.
Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) trade information
Biomarin Pharmaceutical Inc. (BMRN) registered a -8.76% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -8.76% in intraday trading to $83.21, hitting a weekly high. The stock’s 5-day price performance is -7.62%, and it has moved by -5.16% in 30 days. Based on these gigs, the overall price performance for the year is -12.93%.
Biomarin Pharmaceutical Inc. (BMRN) estimates and forecasts
Statistics show that Biomarin Pharmaceutical Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Biomarin Pharmaceutical Inc. (BMRN) shares have gone down -0.17% during the last six months, with a year-to-date growth rate more than the industry average at 32.69% against 12.90. In the rating firms’ projections, revenue will increase 14.00% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 668.85M as predicted by 23 analyst(s). Meanwhile, a consensus of 23 analyst(s) estimates revenue growth to 693.33M by the end of current fiscal year.
While earnings are projected to return 89.60% in 2024, the next five years will return 43.00% per annum.
BMRN Dividends
Biomarin Pharmaceutical Inc. is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
